EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MIL-100(Fe)-Enabled Oral Delivery of Syringic Acid with Enhanced Pharmacokinetics

Joshua H Santos iD, Hannah Jean Victoriano, Mary Sepulveda, Hung-En Liu, Shierrie Mae N Valencia, Rikkamae Zinca Marie L Walde, Emelda A Ongo, Chia-Her Lin iD

Pharmaceutics · 01.10.2025 · 17 (10) · 1282

DOI: 10.3390/pharmaceutics17101282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 01.10.2025. Verfasst von Joshua H Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science and Technology-Central Office, General Santos Avenue, Upper Bicutan, Taguig City 1631, Philippines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology in the Philippines and the Ministry of Science and Technology in Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Plant-derived bioactive compounds like syringic acid, a phenolic acid from the shikimic acid pathway, have shown potential against chronic diseases, including diabetes, cardiovascular disorders, cancer, and cerebral ischemia. However, its poor water solubility and rapid systemic elimination result in low oral bioavailability, limiting therapeutic potential. This study aimed to enhance its oral bioavailability using MIL-100(Fe), a metal–organic framework (MOF) known for high surface area and drug-loading capacity.

Methods

MIL-100(Fe) was synthesized using an optimized method and loaded with syringic acid through impregnation at 12, 24, 36, and 48 h. Characterization included PXRD, FTIR, BET, SEM, and DLS. Acute oral toxicity was evaluated following OECD 423 guidelines, and bioavailability was assessed in Sprague Dawley rats.

Results

The 1:2 MIL-100(Fe) to syringic acid ratio achieved the highest drug loading at 64.42 ± 0.03% (12 h). PXRD and FTIR confirmed successful loading (notably at 1239.2 cm−1), and TGA indicated thermal stability at ~350 °C. SEM revealed octahedral particles with an average size of 270.67 ± 2.60 nm. BET showed reduced surface area post-loading. In vitro drug release exhibited media-dependent profiles. Toxicity tests indicated no adverse effects at 2000 mg/kg. Oral administration of SYA@MIL-100(Fe) resulted in a 10.997-fold increase in relative bioavailability versus oral syringic acid and a 12.82-fold increase compared to intraperitoneal administration.

Conclusions

MIL-100(Fe) is a safe and effective oral carrier for syringic acid, significantly enhancing its bioavailability. This platform shows strong potential for delivering phenolic compounds in pharmaceutical applications.

Schlagwörter

Stichwörter der Autor:innen

AUCMIL-100(Fe)MOFbioavailabilitysyringic acid

Autor:innen und Institutionen

  • Department of Science and Technology-Central Office, General Santos Avenue, Upper Bicutan, Taguig City 1631, Philippines.
  • Department of Science and Technology-Industrial Technology Development Institute, General Santos Avenue, Upper Bicutan, Taguig City 1631, Philippines.
  • Department of Chemistry, National Taiwan Normal University, No. 162, Section 1, Heping E Rd, Da'an District, Taipei City 10610, Taiwan.
  • Department of Chemistry, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan.

ORCID-Profile: Joshua H Santos, Chia-Her Lin

Förderung

  • Department of Science and Technology in the Philippines and the Ministry of Science and Technology in Taiwan

Zitieren

APA

Santos, J. H., Victoriano, H. J., Sepulveda, M., Liu, H. E., Valencia, S. M. N., Walde, R. Z. M. L., Ongo, E. A., & Lin, C. H. (2025). MIL-100(Fe)-Enabled Oral Delivery of Syringic Acid with Enhanced Pharmacokinetics. Pharmaceutics, 17(10), 1282. https://doi.org/10.3390/pharmaceutics17101282

Vancouver

Santos JH, Victoriano HJ, Sepulveda M, Liu HE, Valencia SMN, Walde RZML, et al. MIL-100(Fe)-Enabled Oral Delivery of Syringic Acid with Enhanced Pharmacokinetics. Pharmaceutics. 2025;17(10):1282. doi:10.3390/pharmaceutics17101282

BibTeX
@article{Santos2025,
  author = {Santos, Joshua H and Victoriano, Hannah Jean and Sepulveda, Mary and Liu, Hung-En and Valencia, Shierrie Mae N and Walde, Rikkamae Zinca Marie L and Ongo, Emelda A and Lin, Chia-Her},
  title = {MIL-100(Fe)-Enabled Oral Delivery of Syringic Acid with Enhanced Pharmacokinetics},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {10},
  pages = {1282},
  doi = {10.3390/pharmaceutics17101282}
}
Kostenlos starten →